Ambi Even and Clear Exfoliating Wash Acne Treatment

Description

The product is identified by the SPL Code 34089-3 and is presented in a bottle format. It is associated with a media type of image/jpeg, with a reference image available as Bottle.jpg.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product is to be used twice daily, once in the morning and once in the evening. Prior to application, the area should be wet. A dime-sized amount of the product should be dispensed into the palm, where it should be lathered. The lather should then be gently massaged over the face and neck, ensuring thorough coverage. After massaging, the area must be rinsed well.

This product may also be applied to the chest and back as needed. Due to the potential for excessive drying of the skin, it is recommended to initiate treatment with one application daily. Based on individual tolerance and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily. Should bothersome dryness or peeling occur, it is advisable to reduce the application frequency to once a day or every other day.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Warnings and Precautions

For external use only. The application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that only one topical acne medication be utilized at a time.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Healthcare professionals should advise patients who are pregnant or breastfeeding to consult with a qualified health professional prior to using this product to ensure safety for both the mother and child.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised that only one topical acne medication be applied at a time to minimize the risk of irritation.

This product is intended for external use only. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

For pregnant or breastfeeding individuals, it is recommended to consult a health professional prior to use to ensure safety for both the patient and the child.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Ambi Even and Clear Exfoliating Wash Acne Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily as needed or as directed by a healthcare professional. Should patients experience bothersome dryness or peeling, the frequency of application should be reduced to once a day or every other day.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of data when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding hepatic impairment, including dosage adjustments, special monitoring, or precautions for patients with compromised liver function. Therefore, no specific recommendations can be made for the use of this medication in patients with hepatic impairment. It is advised that healthcare professionals exercise caution and consider individual patient factors when prescribing this medication to patients with liver problems.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are vital to ensure patient safety and effective recovery.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. Skin irritation and dryness may be exacerbated when used concurrently with other topical acne medications. In cases of irritation, it is recommended to limit the use to one topical acne medication at a time.

No relevant information is available regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion.

Additionally, healthcare providers should inform patients about the likelihood of skin irritation and dryness when using this medication in conjunction with other topical acne treatments. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation. This guidance will help ensure the safe and effective use of the medication while reducing the potential for adverse skin reactions.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 59° to 86°F (15° to 30°C) to maintain its efficacy and integrity. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature limits to prevent degradation.

Additional Clinical Information

The medication is administered topically, with a recommended application schedule of every morning and evening. Patients should begin with one application daily, gradually increasing to two or three times daily as needed or directed by a healthcare professional. In cases of bothersome dryness or peeling, it is advised to reduce the application frequency to once a day or every other day.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. Additionally, patients should be informed that the likelihood of skin irritation and dryness increases when using another topical acne medication concurrently. If irritation occurs, it is recommended to limit the use to one topical acne medication at a time.

Drug Information (PDF)

This file contains official product information for Ambi Even and Clear Exfoliating Wash Acne Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)